Concurrent primary vitreoretinal and spinal cord lymphoma: a unique entity

JAMA Ophthalmol. 2014 Jul;132(7):902-4. doi: 10.1001/jamaophthalmol.2014.419.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor / metabolism
  • Biopsy
  • Drug Therapy, Combination
  • Eye Neoplasms / diagnosis*
  • Eye Neoplasms / drug therapy
  • Eye Neoplasms / metabolism
  • Fluorescein Angiography
  • Glucocorticoids / therapeutic use
  • Humans
  • Lymphoma, B-Cell / diagnosis*
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, B-Cell / metabolism
  • Magnetic Resonance Imaging
  • Male
  • Multimodal Imaging
  • Neoplasms, Multiple Primary*
  • Pulse Therapy, Drug
  • Retinal Neoplasms / diagnosis*
  • Retinal Neoplasms / drug therapy
  • Retinal Neoplasms / metabolism
  • Spinal Cord Neoplasms / diagnosis*
  • Spinal Cord Neoplasms / drug therapy
  • Spinal Cord Neoplasms / metabolism
  • Tomography, Optical Coherence
  • Vitrectomy
  • Vitreous Body / drug effects
  • Vitreous Body / metabolism
  • Vitreous Body / pathology*

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Glucocorticoids